Sartorius AG (SOAGY)
58.53
-0.31
(-0.53%)
USD |
OTCM |
Aug 28, 16:00
Sartorius Cash from Operations (Quarterly) : 182.17M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 182.17M |
| March 31, 2026 | 206.38M |
| December 31, 2025 | 350.83M |
| September 30, 2025 | 95.23M |
| June 30, 2025 | 161.47M |
| March 31, 2025 | 135.66M |
| December 31, 2024 | 370.88M |
| September 30, 2024 | 124.37M |
| June 30, 2024 | 298.37M |
| March 31, 2024 | 39.29M |
| December 31, 2023 | 314.88M |
| September 30, 2023 | 135.76M |
| June 30, 2023 | 142.19M |
| March 31, 2023 | 207.94M |
| December 31, 2022 | 279.03M |
| September 30, 2022 | 146.14M |
| June 30, 2022 | 93.06M |
| March 31, 2022 | 210.23M |
| December 31, 2021 | 255.20M |
| September 30, 2021 | 220.38M |
| June 30, 2021 | 247.71M |
| March 31, 2021 | 272.70M |
| December 31, 2020 | 153.99M |
| September 30, 2020 | 183.22M |
| June 30, 2020 | 111.03M |
| Date | Value |
|---|---|
| March 31, 2020 | 117.00M |
| December 31, 2019 | 120.79M |
| September 30, 2019 | 97.33M |
| June 30, 2019 | 57.22M |
| March 31, 2019 | 116.39M |
| December 31, 2018 | 84.90M |
| September 30, 2018 | 77.10M |
| June 30, 2018 | 59.15M |
| March 31, 2018 | 44.49M |
| December 31, 2017 | 89.73M |
| September 30, 2017 | 77.14M |
| June 30, 2017 | 23.95M |
| March 31, 2017 | 23.78M |
| December 31, 2016 | 60.29M |
| September 30, 2016 | 71.98M |
| June 30, 2016 | 26.12M |
| March 31, 2016 | 20.18M |
| December 31, 2015 | 36.08M |
| September 30, 2015 | 33.52M |
| June 30, 2015 | 45.82M |
| March 31, 2015 | 11.86M |
| December 31, 2014 | 88.47M |
| September 30, 2014 | 28.00M |
| June 30, 2014 | 15.12M |
| March 31, 2014 | 23.42M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Mesa Laboratories, Inc. | 14.74M |
| Austar Lifesciences Ltd. | -- |
| SCHOTT Pharma AG & Co. KGaA | 53.57M |
| Agilent Technologies, Inc. | 519.00M |
| Bio-Rad Laboratories, Inc. | 98.70M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -175.22M |
| Cash from Financing (Quarterly) | -340.21M |
| Free Cash Flow | 321.06M |
| Free Cash Flow Per Share (Quarterly) | 0.2453 |
| Free Cash Flow to Equity (Quarterly) | 407.44M |
| Free Cash Flow to Firm (Quarterly) | 128.67M |
| Free Cash Flow Yield | 1.59% |